Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SLC31A1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | RP11-458D21.5 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | EPC1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | GOLPH3L | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | AUH | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | TMSB15A | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | ZNF804B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | GOLGA7 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | DERL2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | RUBCN | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |